Risk Management
View AllContinuing Education
Persistent and Breakthrough Pain: Responsible Opioid Prescribing for Multidimensional Disorders
Jeffrey A. Gudin
2012 Mar 21.
David M. Simpson
2013 Feb 13.
Mark S. Wallace
2012 Jan 09.
David M. Kaufman
2012 Mar 13.
Persistent and Breakthrough Pain: Opioid-Based Therapy for Fluctuating Pain Profiles
Michael J. Brennan
2011 Mar 31.
Michelle I. Rhiner
2012 Aug 31.
David M. Simpson
2013 Feb 13.
Lynn R. Webster
2010 Apr 19.
Cynthia P. Koh-Knox
2012 Mar 07.
- Acute and Post-Operative Pain
- Cancer-related Pain
- Chronic Noncancer Pain
- Comorbid Conditions
- Fibromyalgia
- Headache
- Interventional Modalites
- Low Back Pain
- Medico-Legal-Ethical Issues
- Neuropathic Pain
- Nonopioid Pharmacotherapy
- Nonpharmacologic Treatment
- Opioid Pharmacotherapy
- Osteoarthritis
- Palliative Care
- Risk Management
- Scientific Perspectives
- Special Patient Populations
Journals
Select your area of interest:
PubMed Search
Enter search terms here.
Section Editor
Kenneth L. Kirsh, PhD
Assistant Professor
Department of Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Lexington, Kentucky
Steven D. Passik, PhD
User Activity
Steven D. Passik, PhD
Continuing Education Activities
Associate Attending Psychologist
Department of Psychiatry and Behavioral Sciences
Memorial Sloan-Kettering Cancer Center
Associate Professor of Psychology in Psychiatry
Weill Cornell Medical College
New York, New York
View AllPublications
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
Drug testing, chronic pain,and financial conflicts of interest
Opioid-Paracetamol Prescription Patterns and Liver Dysfunction: A Retrospective Cohort Study in a Population Served by a US Heal
The Opioid Emperor Has No Clothes.
Is Primary Care Providers' Trust in Socially Marginalized Patients Affected by Race?
Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...
J Addict...
Drug testing, chronic pain,and financial conflicts of interest
Collen M, Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR.
Am J Manag Care. 2011 Apr...
Am J Manag Care. 2011 Apr...
Opioid-Paracetamol Prescription Patterns and Liver Dysfunction: A Retrospective Cohort Study in a Population Served by a US Heal
Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN.
Drug Saf. 2011 Nov 1;34(11):1079-88....
Drug Saf. 2011 Nov 1;34(11):1079-88....
The Opioid Emperor Has No Clothes.
Keane M.
Am J Bioeth. 2010 Nov;10(11):25-7.
Am J Bioeth. 2010 Nov;10(11):25-7.
Is Primary Care Providers' Trust in Socially Marginalized Patients Affected by Race?
Moskowitz D, Thom DH, Guzman D, Penko J, Miaskowski C, Kushel M.
J Gen Intern Med. 2011 Mar...
J Gen Intern Med. 2011 Mar...
Clinician.com Links
Some fraction of opioid-treated patients with chronic pain will engage in aberrant substance use, including compulsive drug seeking and addiction.
The World Health Organization has stated that undertreated pain is the number one health problem in America. Sharp rises in unintentional prescription drug overdose rates, however, have caused regulators to move to restrict access to prescription opioids and other potentially abusable medications classes.
The regulatory and reimbursement environment surrounding drug testing is becoming increasingly stringent.
Therapeutic prescription of opioid analgesics has risen sharply in the United States over the last two decades.
Buprenorphine is a partial μ-opioid receptor agonist that is used the treatment of chronic pain and opioid addiction.
During the last two decades, reports of inadequate pain treatment have resulted in increased opioid prescribing, at times by physicians who were not adequately trained in pain and risk management.
Opioid analgesics are increasingly being prescribed for the management of chronic pain despite incomplete evidence for long-term efficacy and the ongoing risk of abuse.
Only a small percentage of chronic pain patients receiving appropriate opioid treatment will become addicted to the medications. In fact, in their patients treated with opioids, healthcare providers are much more likely to face noncompliant behavior than frank addiction.
Chronic noncancer pain is a leading cause of disability, resulting in deleterious effects on multiple patient domains (eg, physical, psychological, cognitive, employment, among others).
Recent guidelines call for assessing the risk for aberrant medication-related behavior in chronic pain sufferers who are candidates for long-term opioid therapy.